| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/27/2005 | US6949354 Detection of nervous system modulators; obtain preferential nervous system tissue in vitro, culture, incubate with modulator, monitor and evaluate adjustment in cell activity |
| 09/27/2005 | US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase |
| 09/27/2005 | US6949346 Using antibody released by hybridomas cells |
| 09/27/2005 | US6949338 Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids |
| 09/27/2005 | US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 09/27/2005 | US6949252 Method for preparing an implantable multilayer tissue construct |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/27/2005 | US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates |
| 09/27/2005 | US6949242 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells |
| 09/27/2005 | CA2250682C Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 09/27/2005 | CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/2005 | CA2099612C Monokine mig induced by ifn-gamma |
| 09/22/2005 | WO2005087936A1 Method of transferring gene into embryonic stem cell |
| 09/22/2005 | WO2005087933A1 Thiol methyltransferase-based selection |
| 09/22/2005 | WO2005087928A1 Proteins imparting boron-tolerance and genes thereof |
| 09/22/2005 | WO2005087927A1 Method for preparation and purification or recombinant proteins |
| 09/22/2005 | WO2005087915A2 Use of ethanolamine for enhancing cell growth in membrane systems |
| 09/22/2005 | WO2005087287A1 Novel tissue engineered scaffolds derived from copper capillary alginate gels |
| 09/22/2005 | WO2005087286A1 Biological tissue sheet, method of forming the same and transplantation method by using the sheet |
| 09/22/2005 | WO2005087285A1 Corneal epithelial sheet, method of constructing the same and transplantation method using the sheet |
| 09/22/2005 | WO2005087239A1 Tissue repair with multipotent cells |
| 09/22/2005 | WO2005087001A1 A method for the dryness preservation of biological fluid samples and the device thereof |
| 09/22/2005 | WO2005086881A2 Modulation of cell intrinsic strain to control cell modulus, matrix synthesis, secretion, organization, material properties and remodeling of tissue engineered constructs |
| 09/22/2005 | WO2005086860A2 Methods for generating insulin-producing cells |
| 09/22/2005 | WO2005086845A2 Compositions and methods for growth of embryonic stem cells |
| 09/22/2005 | WO2005086781A2 Regulatory t cells and their use in immunotherapy and suppression of autoimmune responses |
| 09/22/2005 | WO2005086667A2 High efficiency peptide production in plant cells |
| 09/22/2005 | WO2005086654A2 Self-cleaving affinity tags and methods of use |
| 09/22/2005 | WO2005086595A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 09/22/2005 | WO2005061019A3 Methods and composition for soft tissue feature reconstruction |
| 09/22/2005 | WO2005052139A3 Method of inducing memory b cell development and terminal differentiation |
| 09/22/2005 | WO2005049072A3 Therapeutic cancer vaccine with fragments of trag-3 |
| 09/22/2005 | WO2005044981A3 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/22/2005 | WO2004096995A3 Recombinant plant dicer |
| 09/22/2005 | WO2003092471A3 Cell-seeded extracellular matrix grafts |
| 09/22/2005 | WO2000075279A3 Nucleotide sequences for gene regulation and methods of use thereof |
| 09/22/2005 | US20050210549 Sesquiterpene synthases and methods of use |
| 09/22/2005 | US20050210548 Hydrolase expressed in transgenic plants for improving feed digestibility in baking and brewing |
| 09/22/2005 | US20050210546 Generation of plants with improved pathogen resistance |
| 09/22/2005 | US20050210545 Expression vector comprising nucleotide sequences coding insecticidal proteins for use in transformation and propagation of insect resistant crop plants; biological pest control |
| 09/22/2005 | US20050210542 relates to seeds, plants of soybean 0509214 and to methods for producing soybean plant by crossing soybean 0509214 with itself or another soybean line, and the creation of variants by mutagenesis or transformation of soybean 0509214; tolerance to glyphosate; lodging resistance |
| 09/22/2005 | US20050210541 Using sperm adhesion molecule 1 (SPAM 1) as tool to enhance sperm attachment to egg; in vitro fertilization |
| 09/22/2005 | US20050210540 Expression vector comprising nucleotide sequence coding glycine transport protein for use in generating animal models which identify modulators of psychotic behavior |
| 09/22/2005 | US20050210537 Using cardiomyocyte nuclear transplantion in generation of hybrid cells |
| 09/22/2005 | US20050209687 Artificial vessel scaffold and artifical organs therefrom |
| 09/22/2005 | US20050209145 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 09/22/2005 | US20050209140 Methods of controlling axonal growth |
| 09/22/2005 | US20050209137 Assaying sample for the binding of leptin to an avian leptin receptor binding domain bound to a solid phase (microtitre well plate) and detecting the bound leptin by using a labeled (radiolabeled, chemiluminescent, electroluminescent, fluorescent, enzyme-labeled, or bioluminescent) anti-leptin antibody. |
| 09/22/2005 | US20050209081 Autologous platelet gel spray delivery system |
| 09/22/2005 | US20050208660 Infecting a eukaryotic cell with a vactor system having DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct |
| 09/22/2005 | US20050208659 Using adenoviral transformation/transfection to transfer cyclin and cyclin dependent kinase genes into nucleus of differentiated cells; regenerative medicine and tissue engineering |
| 09/22/2005 | US20050208656 Adhesive mix comprising photocatalyst for adhering cells to solid support |
| 09/22/2005 | US20050208655 Blood cells having modified antigenicity |
| 09/22/2005 | US20050208654 Process for producing T lymphocytes |
| 09/22/2005 | US20050208653 Pancreatic progenitor cell culture for use in prevention and treatment of infection, diabetes and liver disorders |
| 09/22/2005 | US20050208652 Isogenic beta-catenin cell lines, and methods of making and using same |
| 09/22/2005 | US20050208651 Propagating premature oocyte in nutrient broth comprising fibroblast growth factor, epidermal growth factor, vitamins, amino acids and insulin containing protein; in vitro fertilization |
| 09/22/2005 | US20050208650 Application apparatus of 3-dimensional klinostat and method of growing object using the same |
| 09/22/2005 | US20050208638 Process for preparing bioactive protein-enriched whey products |
| 09/22/2005 | US20050208632 Method for producing 2'-deoxyribonucleoside |
| 09/22/2005 | US20050208628 Methods and vectors for generating antibodies in avian species and uses therefor |
| 09/22/2005 | US20050208627 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 09/22/2005 | US20050208625 Monoclonal antibodies with reduced immunogenicity |
| 09/22/2005 | US20050208624 Fluorescent protein |
| 09/22/2005 | US20050208619 29 human secreted proteins |
| 09/22/2005 | US20050208599 Using immunoglobulins specific to dendritic cell-specific adhesion receptors (DC-SIGN) as tool in isolation of preferential nervous system tissues |
| 09/22/2005 | US20050208591 Antibodies to chemokine alpha-6 |
| 09/22/2005 | US20050208580 Novel protein and method for producing the protein |
| 09/22/2005 | US20050208565 29 human cancer associated proteins |
| 09/22/2005 | US20050208560 Using immunoglobulins to identify staphylococcal peptides associated with viriginiamycin resistant |
| 09/22/2005 | US20050208552 Corpuscles of Stannius protein, stanniocalcin |
| 09/22/2005 | US20050208546 Nucleotide sequences coding tumor associated antigens for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/22/2005 | US20050208536 Comprises ribonuclease barnase marker gene; libraries; drug resistance |
| 09/22/2005 | US20050208533 Modulators of morphogen expression and methods of identifying the same |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | US20050208522 Fibroblast growth factor-like molecules and uses thereof |
| 09/22/2005 | US20050208490 Ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3) and uses thereof |
| 09/22/2005 | US20050208489 Targeted chromosomal mutagenasis using zinc finger nucleases |
| 09/22/2005 | US20050208484 Isolated nucleic acid molecules encoding human drugmetobolizing proteins |
| 09/22/2005 | US20050208481 Using feline immunedeficiency viral (FIV) envelope protein as screening tool in monoclonal antibody detection |
| 09/22/2005 | US20050208478 Biological scaffold comprising connective tissue protein for use in identifying angents which delay cutaneous aging |
| 09/22/2005 | US20050208476 Propagating mammalian tissues in solid matrix; tissue engineering; regenerative medicine; tisse transplantation |
| 09/22/2005 | US20050208474 Method and cell composition for screening compounds for anti-inflammatory activity |
| 09/22/2005 | US20050208466 Method of selective isolation or visualization of target cells differentiated from embryonic cells or kit for visualization |
| 09/22/2005 | US20050208120 artificial antigen presenting cell comprising liposome comprising a fluid lipid bilayer; MHC class I and/or class II molecule associated with the bilayer complexed with an antigenic peptide; and accessory molecules associated with the bilayer; for treating autoimmune disorders, allergies, cancers, etc. |
| 09/22/2005 | US20050208071 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species |
| 09/22/2005 | US20050208056 Neoplasm specific antibodies and uses thereof |
| 09/22/2005 | US20050208055 Monoclonal antibodies; hybridoma cell lines; for use in Western blot analysis, immunohistochemisty, protein purification; diagnosis of cancer and vitamin D metabolic conditions; drug screening |
| 09/22/2005 | US20050208049 Expanding CD4 + T cells; antiretroviral drug; induce active pathogen replication in cell latently infected with HIV and anti-pathogen drug |
| 09/22/2005 | US20050208046 TWEAK receptor |
| 09/22/2005 | US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin |
| 09/22/2005 | US20050208040 Polynucleotides and polypeptides encoded thereby |
| 09/22/2005 | US20050208036 Graft versus host disease; administering lymphocytes ,hematopoietic stem cells |
| 09/22/2005 | US20050208030 Myocardial grafts and cellular compositions useful for same |
| 09/22/2005 | US20050208029 Method of forming pancreatic beta cells from mesenchymal cells |
| 09/22/2005 | US20050208028 Nutrient Medium for maintaining neural cells in injured nervous system |
| 09/22/2005 | US20050208027 Methods and compositions for regeneration of aged tissues |
| 09/22/2005 | US20050208026 Tissue engineered uterus |
| 09/22/2005 | US20050208025 Enhancement of hematopoietic stem cell survival |
| 09/22/2005 | US20050208024 Treating cancer in humans; obtain human, administer antitumor agent, evaluate tumor response to antitumor agents |